CARMEN LAMBERT GOITIA-rekin lankidetzan egindako argitalpenak (12)

2024

  1. 100 Years since the Discovery of Insulin, from Its Discovery to the Insulins of the Future

    Biomedicines, Vol. 12, Núm. 3

  2. Hypoglycemia during hyperosmolar hyperglycemic crises is associated with long-term mortality

    Diabetology and Metabolic Syndrome, Vol. 16, Núm. 1

  3. Metformin and Glucose Concentration as Limiting Factors in Retinal Pigment Epithelial Cell Viability and Proliferation

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2023

  1. A long non-coding RNA that harbors a SNP associated with type 2 diabetes regulates the expression of TGM2 gene in pancreatic beta cells

    Frontiers in Endocrinology, Vol. 14

  2. Circulating miRNA expression in long-standing type 1 diabetes mellitus

    Scientific Reports, Vol. 13, Núm. 1

  3. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Asturias (Spain) between 2011 and 2020: influence of symptom duration on prevalence of ketoacidosis and weight loss

    Revista Espanola de Salud Publica, Vol. 97

  4. Diabetic ketoacidosis at diagnosis of type 1 diabetes in Asturias (Spain) between 2011 and 2020: influence of symptom duration on prevalence of ketoacidosis and weight loss

    Revista espanola de salud publica, Vol. 97

  5. Hypoglycemia in patients with type 2 diabetes mellitus during hospitalization: associated factors and prognostic value

    Diabetology and Metabolic Syndrome, Vol. 15, Núm. 1

  6. Reclassification of type 2 diabetes to type 1 diabetes in Asturias (Spain) between 2011 and 2020

    Diabetology and Metabolic Syndrome, Vol. 15, Núm. 1

  7. miR-24-3p and Body Mass Index as Type 2 Diabetes Risk Factors in Spanish Women 15 Years after Gestational Diabetes Mellitus Diagnosis

    International Journal of Molecular Sciences, Vol. 24, Núm. 2

2022

  1. Correlation between glucose measurement parameters of continuous flash monitoring and HbA1c. Real life experience in Asturias

    Endocrinologia, Diabetes y Nutricion, Vol. 69, Núm. 7, pp. 493-499

  2. Real-life effects of adding weekly subcutaneous semaglutide to insulin for the treatment of type 2 diabetes mellitus

    Revista Clinica Espanola, Vol. 222, Núm. 9, pp. 516-522